Cancer Research UK logo.
SearchDonate
  • Search

A study of veliparib with carboplatin and paclitaxel and continued as maintenance treatment for ovarian cancer that has spread

Overview

Cancer types:

Ovarian cancer, Secondary cancers

Status:

Results

Phase:

Phase 3

Details

This study looked at having veliparib with chemotherapy and then continuing it as maintenance treatment for ovarian cancer that has spread.

It included women with:

  • ovarian cancer

  • fallopian tube cancer

  • primary peritoneal cancer

Doctors treat these cancers in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.

This study was open for women to join between 2015 and 2017. The team published the results in 2019.

Recruitment start: 1 October 2015

Recruitment end: 8 May 2017

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Shibani Nicum

Supported by

AbbVie

Last reviewed: 26 May 2021

CRUK internal database number: 13671

Help and support